Receptors, Complement 3d: Clinical Trials

1 trial of Receptors, Complement 3d, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Receptors, Complement 3d: new trials by email Literature Review of Receptors, Complement 3d trials Research Report on Receptors, Complement 3d

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chidamide, Lenalidomide, and Rituximab in Newly Diagnosed Elderly/unFit DE-DLBCL
Chidamide in combination with Lenalidomide and Rituximab (CR2) - Double Expressor DLBCL, ELDERLY PEOPLE
Phase 2RecruitingThe First Affiliated Hospital with Nanjing Medical University382024-03-112026-10-20

Sponsors

The First Affiliated Hospital with Nanjing Medical University (1)

Countries

China (1)